Resources from the same session
786O - Tumor biomarker analysis from COLUMBUS part 1: Encorafenib + binimetinib for BRAF V600E/K-mutant advanced or metastatic melanoma
Presenter: Reinhard Dummer
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
788O - Association of pre-treatment ctDNA with disease recurrence and clinical and translational factors in patients with stage IIIB-D/IV melanoma treated with adjuvant immunotherapy (CheckMate 915)
Presenter: Georgina Long
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Invited Discussant 786O and 788O
Presenter: Sapna Patel
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Webcast
787O - Adjuvant immunotherapy with nivolumab (NIVO) versus observation in completely resected Merkel cell carcinoma (MCC): Disease-free survival (DFS) results from ADMEC-O, a randomized, open-label phase II trial
Presenter: Jürgen C Becker
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
789O - Neoadjuvant cemiplimab in patients (pts) with stage II–IV (M0) cutaneous squamous cell carcinoma (CSCC): Primary analysis of a phase II study
Presenter: Neil Gross
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Abstract
Slides
Webcast
Q&A
Presenter: All Speakers
Session: Proffered Paper session 2: Melanoma and other skin tumours
Resources:
Webcast